Clinical Trial Update: Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer [NA]

View source ↗

Summary

A completed clinical trial is evaluating neoadjuvant Diffusing Alpha Emitters Radiation Therapy (DaRT) brachytherapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Diffusing Alpha Emitters Radiation Therapy (DaRT) (diffusing alpha emitters radiation therapy)

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Prostate Adenocarcinoma | NA | Status: COMPLETED